Literature DB >> 17507516

Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.

Maria Claudia Nascimento1, Suzete Ferreira, Ester Sabino, Ingrid Hamilton, John Parry, Claudio S Pannuti, Philippe Mayaud.   

Abstract

A total of 586 serum samples were used to evaluate the performance of type-specific herpes simplex virus type 2 (HSV-2) commercial enzyme-linked immunosorbent assays (ELISAs) by using the monoclonal antibody-blocking enzyme immunoassay (MAb-EIA) and a clinicovirological panel as reference standards. The Kalon and HerpeSelect ELISAs had similar sensitivities (93.5% and 93.8% compared with the results obtained by MAb-EIA, respectively, and 100% for both ELISAs compared with the results obtained with a clinicovirological panel). The Kalon ELISA had a higher specificity (96.5% and 96.8% compared with the results obtained by MAb-EIA and with a clinicovirological panel, respectively) than the HerpeSelect ELISA (86.9% and 94% compared with the results obtained by MAb-EIA and with a clinicovirological panel, respectively). A higher cutoff significantly improved the specificity of the HerpeSelect ELISA.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17507516      PMCID： PMC1933020          DOI： 10.1128/JCM.00144-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Herpes simplex virus type 2 in the United States, 1976 to 1994.

Authors:  D T Fleming; G M McQuillan; R E Johnson; A J Nahmias; S O Aral; F K Lee; M E St Louis
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

2.  Genital herpes--how much of a public-health problem?

Authors:  A Mindel
Journal:  Lancet       Date:  1998       Impact factor: 79.321

3.  Detection and direct typing of herpes simplex virus in perianal ulcers of patients with AIDS by PCR.

Authors:  M C do Nascimento; L M Sumita; V A de Souza; C S Pannuti
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

4.  Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations.

Authors:  Eddy van Dyck; Anne Buvé; Helen A Weiss; Judith R Glynn; David W G Brown; Bénédicte De Deken; John Parry; Richard J Hayes
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

5.  Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.

Authors:  R Ashley-Morrow; J Nollkamper; N J Robinson; N Bishop; J Smith
Journal:  Clin Microbiol Infect       Date:  2004-06       Impact factor: 8.067

6.  Monoclonal antibody blocking tests for the detection of HSV-1- and HSV-2-specific humoral responses: comparison with western blot assay.

Authors:  M J Slomka; R L Ashley; F M Cowan; A Cross; D W Brown
Journal:  J Virol Methods       Date:  1995-09       Impact factor: 2.014

7.  Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.

Authors:  Anna Wald; Rhoda Ashley-Morrow
Journal:  Clin Infect Dis       Date:  2002-10-15       Impact factor: 9.079

8.  Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition.

Authors:  Wayne Hogrefe; Xin Su; James Song; Rhoda Ashley; Lilly Kong
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

9.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948
View more
  11 in total

1.  Evaluation of the HerpeSelect Express rapid test in the detection of herpes simplex virus type 2 antibodies in patients with genital ulcer disease.

Authors:  Hani Al-Shobaili; Khaled M Hassanein; Marwa Salah Mostafa; Ali Saleh Al Duways
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

2.  Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.

Authors:  J S Smith; R C Bailey; D J Westreich; I Maclean; K Agot; J O Ndinya-Achola; W Hogrefe; R A Morrow; S Moses
Journal:  Sex Transm Infect       Date:  2008-10-27       Impact factor: 3.519

3.  Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.

Authors:  Jérôme LeGoff; Philippe Mayaud; Gérard Gresenguet; Helen A Weiss; Khonde Nzambi; Eric Frost; Jacques Pepin; Laurent Belec
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

4.  Population-based seroprevalence of HSV-2 and syphilis in Andhra Pradesh state of India.

Authors:  John A Schneider; Vemu Lakshmi; Rakhi Dandona; G Anil Kumar; Talasila Sudha; Lalit Dandona
Journal:  BMC Infect Dis       Date:  2010-03-09       Impact factor: 3.090

5.  Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region.

Authors:  Vanda A U F de Souza; Laura M Sumita; Maria-Claudia Nascimento; Juliane Oliveira; Melissa Mascheretti; Mariana Quiroga; Wilton S Freire; Adriana Tateno; Marcos Boulos; Philippe Mayaud; Claudio S Pannuti
Journal:  J Infect Dis       Date:  2007-08-06       Impact factor: 5.226

6.  Comparison of a multiplexed herpes simplex virus type-specific immunoglobulin G serology assay to immunoblot, Western blot, and enzyme-linked immunosorbent assays.

Authors:  Thomas B Martins; Ryan J Welch; Harry R Hill; Christine M Litwin
Journal:  Clin Vaccine Immunol       Date:  2008-11-19

7.  Performance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.

Authors:  Jérôme LeGoff; Gérard Grésenguet; Chrysostome Gody; Jean De Dieu Longo; Nzambi Khonde; Helen A Weiss; Philippe Mayaud; Laurent Bélec
Journal:  Clin Vaccine Immunol       Date:  2011-05-11

8.  Prevalence and incidence estimation of HSV-2 by two IgG ELISA methods among South African women at high risk of HIV.

Authors:  Irith De Baetselier; Joris Menten; Vicky Cuylaerts; Khatija Ahmed; Jennifer Deese; Lut Van Damme; Tania Crucitti
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

9.  Population and dyadic-based seroincidence of herpes simplex virus-2 and syphilis in southern India.

Authors:  Chad H Hochberg; John A Schneider; Rakhi Dandona; Vemu Lakshmi; G Anil Kumar; Talasila Sudha; Mohammed Akbar; G Md Mushtaq Ahmed; Sri P Ramgopal; Benjamin Armbruster; Michel Alary; Lalit Dandona
Journal:  Sex Transm Infect       Date:  2015-01-20       Impact factor: 3.519

10.  Seroprevalence of Kaposi sarcoma-associated herpesvirus and other serologic markers in the Brazilian Amazon.

Authors:  Maria C Nascimento; Laura M Sumita; Vanda U Souza; Helen A Weiss; Juliane Oliveira; Melissa Mascheretti; Mariana Quiroga; Rodrigo A R Vela; Ester Sabino; Claudio S Pannuti; Philippe Mayaud
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.